Answer:
Regulations on medicines laid down by the European Union and the granting of marketing authorisations with validity in all member states considerably increased the free movement of medicines. This made it even more important to reconsider the methods for the analytical supervision of marketed medicines, which was previously carried out by individual national authorities. Thus, a co-ordinated European approach to controlling medicines was set- up. For more information about the Network’s mission, please see our webpage.
EDQM FAQs
